We use cookies to provide you with a better experience. By continuing to browse the site you are agreeing to our use of cookies in accordance with our Cookie Policy.
The CEO of French drug major sanofi-aventis, Jean-Francois Dehecq,
and European research-based sector association EFPIA have claimed that the European
Union's (EU) parallel trade is set to decline this year.
According to a new survey of active pharmaceutical ingredient (API)
manufacturing in India, the sector could play a critical role in the development
of higher-tech applications.
Hemosol announced that it has filed articles of amendment for the consolidation
of the company's common shares on the basis of one post-consolidation share
for four pre-consolidation shares.
Azur Pharma, the biotech firm headed by former Elan executive, Seamus Mulligan,
said it has successfully completed a private placement of equity securities
worth E40 million.
Vertex Pharmaceuticals Incorporated announced the pricing of its public offering
of 11,750,000 shares of its common stock at a price of $13.00 per share.
Medicago and InterveXion Therapeutics have formed a multi-year product co-development
collaboration, which will use Medicago's Proficia Protein Technology for the
production of monoclonal antibodies therapeutics designed to treat drug abuse.
Kainos Laboratories announced on June 7 that it has signed a sales agreement
with Towa Pharmaceutical, one of the leading Japanese generic drug manufacturers,
on Statmark Influenza A/B, Kainos' proprietary influenza virus detection kit
co-developed with Nichirei.
Drugmaker Ind Swift Ltd. is implementing a Rs 1 billion
expansion programme, which is likely to be completed within nine months, it
told the Bombay Stock Exchange on Tuesday.